1. Home
  2. TREE vs PBYI Comparison

TREE vs PBYI Comparison

Compare TREE & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$30.44

Market Cap

533.1M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.77

Market Cap

434.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
PBYI
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.1M
434.2M
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
TREE
PBYI
Price
$30.44
$7.77
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$71.25
N/A
AVG Volume (30 Days)
193.5K
323.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
1.22
N/A
Revenue
$1,117,324,000.00
$27,685,000.00
Revenue This Year
$19.03
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$32.34
N/A
Revenue Growth
24.12
N/A
52 Week Low
$32.65
$3.03
52 Week High
$77.35
$8.75

Technical Indicators

Market Signals
Indicator
TREE
PBYI
Relative Strength Index (RSI) 41.12 46.24
Support Level $39.05 $7.67
Resistance Level $39.74 $7.83
Average True Range (ATR) 2.23 0.40
MACD -0.82 -0.08
Stochastic Oscillator 9.01 17.54

Price Performance

Historical Comparison
TREE
PBYI

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: